{"transactions":[{"id":961094,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-22T21:10:10.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-124533","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025124533/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":985186,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-12-01T21:10:12.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-116675","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025116675/ownership.xml","form_type":"4/A","original_submission_date":"2025-09-23"}},{"id":1033840,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-23T20:10:23.000Z","date":"2025-09-19","kind":"grant","planned":false,"acquired":true,"shares":1700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the \"Company\") or a Related Entity (as defined in the award agreement) as of the applicable vesting date."}],"balance_after":1700000,"source":{"system":"sec-edgar","filing":"0001213900-25-090614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390025090614/ownership.xml","form_type":"4"}},{"id":1033676,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":89388,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":89388,"derivative":{"exercise_price":19.25,"expiration_date":"2026-09-27","underlying":"Common Stock","underlying_shares":89388},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033675,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":89388,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2025 to September 27, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":19.25,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":89388},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033674,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"grant","planned":false,"acquired":true,"shares":125490,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":125490,"derivative":{"exercise_price":28.75,"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":125490},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1033673,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2025-09-23T16:05:24.000Z","date":"2025-08-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125490,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2025 to August 14, 2026, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":28.75,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":125490},"source":{"system":"sec-edgar","filing":"0001213900-25-090602","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390025090602/ownership.xml","form_type":"4"}},{"id":1330936,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-16T21:05:56.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, provided that Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":800000,"derivative":{"exercise_price":1.07,"expiration_date":"2034-12-12","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001213900-24-109293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024109293/ownership.xml","form_type":"4"}},{"id":1368770,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Purchase Common Stock)","published_at":"2024-11-12T17:00:25.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on November 7, 2024. The options vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":600000,"derivative":{"exercise_price":0.38,"expiration_date":"2034-11-07","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001213900-24-096892","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024096892/ownership.xml","form_type":"4"}},{"id":1398430,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-09-25","kind":"grant","planned":false,"acquired":true,"shares":2234700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":2234700,"derivative":{"exercise_price":0.77,"expiration_date":"2025-09-27","underlying":"Common Stock","underlying_shares":2234700},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398429,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-09-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2234700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from September 27, 2024 to September 27, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on September 27, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":2234700},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398428,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-08-14","kind":"grant","planned":false,"acquired":true,"shares":3137255,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":3137255,"derivative":{"exercise_price":1.15,"expiration_date":"2025-08-14","underlying":"Common Stock","underlying_shares":3137255},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1398427,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-09-27T17:26:03.000Z","date":"2024-08-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3137255,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from August 14, 2024 to August 14, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on August 13, 2018 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2024-08-14","underlying":"Common Stock","underlying_shares":3137255},"source":{"system":"sec-edgar","filing":"0001213900-24-082812","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024082812/ownership.xml","form_type":"4"}},{"id":1419062,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-30T20:05:15.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":3700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This Form 4 has been amended to correct the amount of option shares held by the Reporting Person."}],"balance_after":3700000,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":3700000},"source":{"system":"sec-edgar","filing":"0001213900-24-074519","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024074519/ownership.xml","form_type":"4/A","original_submission_date":"2024-08-14"}},{"id":1433853,"issuer":{"id":6935,"kind":"organization","name":"CITIUS ONCOLOGY, INC."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T22:27:01.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":1233333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, originally issued by Citius Oncology Sub, Inc., vests over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, provided that the Reporting Person provides continuous services to Citius Oncology Sub, Inc. or a related entity as of each such vesting date. The option was assumed by Citius Oncology, Inc. in the merger transaction, which closed August 12, 2024."}],"balance_after":1233333,"derivative":{"exercise_price":2.15,"expiration_date":"2033-07-05","underlying":"Common Stock","underlying_shares":1233333},"source":{"system":"sec-edgar","filing":"0001213900-24-069248","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851484/000121390024069248/ownership.xml","form_type":"4"}},{"id":1436101,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2024-08-12T21:18:00.000Z","date":"2024-08-09","kind":"grant","planned":false,"acquired":true,"shares":2353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 9, 2024, the Reporting Person was granted options (\"Options\") to purchase up to 2,353 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant."}],"balance_after":27353,"derivative":{"exercise_price":2.925,"expiration_date":"2034-08-09","underlying":"Common stock","underlying_shares":2353},"source":{"system":"sec-edgar","filing":"0001493152-24-031367","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315224031367/ownership.xml","form_type":"4"}},{"id":1546618,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:21.000Z","date":"2024-04-03","kind":"grant","planned":false,"acquired":true,"shares":1165048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":1165048,"derivative":{"exercise_price":1.42,"expiration_date":"2025-04-05","underlying":"Common Stock","underlying_shares":1165048},"source":{"system":"sec-edgar","filing":"0001213900-24-030811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024030811/ownership.xml","form_type":"4"}},{"id":1546617,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Warrant to Purchase Common Stock","published_at":"2024-04-05T16:05:21.000Z","date":"2024-04-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1165048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the \"old\" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately."}],"balance_after":0,"derivative":{"exercise_price":1.42,"expiration_date":"2024-04-05","underlying":"Common Stock","underlying_shares":1165048},"source":{"system":"sec-edgar","filing":"0001213900-24-030811","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390024030811/ownership.xml","form_type":"4"}},{"id":1745852,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2023-11-10T00:48:36.000Z","date":"2023-11-07","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 7, 2023, the Reporting Person was granted options (\"Options\") to purchase up to 25,000 shares of the Registrant's common stock pursuant to the Registrant's 2023 Omnibus Equity Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":0.1577,"expiration_date":"2033-11-07","underlying":"Common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001493152-23-040165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315223040165/ownership.xml","form_type":"4"}},{"id":1761110,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2023-10-12T16:15:21.000Z","date":"2023-10-10","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":550000,"derivative":{"exercise_price":0.7,"expiration_date":"2033-10-10","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001013762-23-003528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000101376223003528/ownership.xml","form_type":"4"}},{"id":2141247,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Option to Purchase Common Stock","published_at":"2022-10-06T16:08:28.000Z","date":"2022-10-04","kind":"grant","acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":550000,"derivative":{"exercise_price":1.25,"expiration_date":"2032-10-04","underlying":"Common Stock","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001213900-22-062481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390022062481/ownership.xml","form_type":"4"}},{"id":2320214,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (right to buy)","published_at":"2022-03-23T20:15:43.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 21, 2022, the Reporting Person was granted options (\"Options\") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2019 Stock Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":1.33,"expiration_date":"2032-03-21","underlying":"Common stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-22-007541","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315222007541/ownership.xml","form_type":"4"}},{"id":2433934,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Note","published_at":"2022-01-18T21:09:20.000Z","date":"2022-01-14","kind":"exercise","acquired":false,"price":0,"reported_value":300000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On December 22, 2020, the Registrant issued the Reporting Person a $300,000 note which matures on the earlier of (i) December 31, 2023 and (ii) the closing of the Next Equity Financing. The note shall automatically convert into the type of Equity Securities issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock. \"Next Equity Financing\" means the next sale (or series of related sales) by the Registrant of its Equity Securities pursuant to which the Registrant receives gross proceeds of not less than $7.5 million (inclusive of the aggregate amount of debt securities converted into Equity Securities upon conversion or cancellation of notes). \"Equity Securities\" means, subject to certain exceptions, the Registrant's common stock and common stock equivalents."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On December 22, 2020, the Registrant issued the Reporting Person a $300,000 note which matures on the earlier of (i) December 31, 2023 and (ii) the closing of the Next Equity Financing. The note shall automatically convert into the type of Equity Securities issued in the Next Equity Financing. Pursuant to the terms of the note, because the Registrant's initial public offering qualified as a Next Equity Financing, the note automatically converted into shares of the Registrant's common stock. \"Next Equity Financing\" means the next sale (or series of related sales) by the Registrant of its Equity Securities pursuant to which the Registrant receives gross proceeds of not less than $7.5 million (inclusive of the aggregate amount of debt securities converted into Equity Securities upon conversion or cancellation of notes). \"Equity Securities\" means, subject to certain exceptions, the Registrant's common stock and common stock equivalents."}],"balance_after":0,"derivative":{"exercise_price":3.2,"underlying":"Common stock","underlying_shares":98733},"source":{"system":"sec-edgar","filing":"0001493152-22-001473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315222001473/ownership.xml","form_type":"4"}},{"id":2433933,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T21:09:20.000Z","date":"2022-01-14","kind":"purchase","acquired":true,"shares":25000,"price":4,"value":100000.0,"ownership":{"direct":true},"balance_after":123733,"source":{"system":"sec-edgar","filing":"0001493152-22-001473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315222001473/ownership.xml","form_type":"4"}},{"id":2433932,"issuer":{"id":6394,"kind":"organization","name":"Canton Strategic Holdings, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-18T21:09:20.000Z","date":"2022-01-14","kind":"exercise","acquired":true,"shares":98733,"price":3.2,"value":315945.6,"ownership":{"direct":true},"balance_after":98733,"source":{"system":"sec-edgar","filing":"0001493152-22-001473","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1861657/000149315222001473/ownership.xml","form_type":"4"}},{"id":2543355,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Option to Purchase Common Stock","published_at":"2021-10-13T17:25:45.000Z","date":"2021-10-11","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":650000,"derivative":{"exercise_price":2.04,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001213900-21-052677","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390021052677/ownership.xml","form_type":"4"}},{"id":2624828,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2021-07-26T17:02:17.000Z","date":"2021-07-22","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":2,"expiration_date":"2031-07-22","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001213900-21-038695","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390021038695/ownership.xml","form_type":"4"}},{"id":3009338,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2020-10-09T16:07:13.000Z","date":"2020-10-06","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting\nCommencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.01,"expiration_date":"2030-10-06","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-20-030793","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390020030793/ownership.xml","form_type":"4"}},{"id":3394728,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2019-10-10T16:14:02.000Z","date":"2019-10-08","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date."}],"balance_after":175000,"derivative":{"exercise_price":0.67,"expiration_date":"2029-10-08","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001213900-19-020122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019020122/ownership.xml","form_type":"4"}},{"id":3405177,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-09-27T16:16:49.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":2234700,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":2234700,"derivative":{"exercise_price":0.77,"expiration_date":"2024-09-27","underlying":"Common Stock","underlying_shares":2234700},"source":{"system":"sec-edgar","filing":"0001213900-19-019180","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019019180/ownership.xml","form_type":"4"}},{"id":3405176,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-09-27T16:16:49.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":2234700,"price":0.8951,"value":2000279.97,"ownership":{"direct":true},"balance_after":10255343,"source":{"system":"sec-edgar","filing":"0001213900-19-019180","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019019180/ownership.xml","form_type":"4"}},{"id":3561317,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2019-04-05T16:06:35.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":1165048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":1615048,"derivative":{"exercise_price":1.42,"expiration_date":"2021-04-05","underlying":"Common Stock","underlying_shares":1165048},"source":{"system":"sec-edgar","filing":"0001213900-19-005844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019005844/ownership.xml","form_type":"4"}},{"id":3561316,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2019-04-05T16:06:35.000Z","date":"2019-04-03","kind":"purchase","acquired":true,"shares":1165048,"price":1.545,"value":1799999.16,"ownership":{"direct":true},"balance_after":8020643,"source":{"system":"sec-edgar","filing":"0001213900-19-005844","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390019005844/ownership.xml","form_type":"4"}},{"id":3823369,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Options to Purchase Common Stock","published_at":"2018-09-06T16:14:57.000Z","date":"2018-09-04","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.62,"expiration_date":"2028-09-04","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-18-012199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018012199/ownership.xml","form_type":"4"}},{"id":3843270,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-08-15T17:07:13.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":3137255,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":3137255,"derivative":{"exercise_price":1.15,"expiration_date":"2023-08-14","underlying":"Common Stock","underlying_shares":3137255},"source":{"system":"sec-edgar","filing":"0001213900-18-011213","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018011213/ownership.xml","form_type":"4"}},{"id":3843269,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-08-15T17:07:13.000Z","date":"2018-08-13","kind":"purchase","acquired":true,"shares":3137255,"price":1.275,"value":4000000.125,"ownership":{"direct":true},"balance_after":6855595,"source":{"system":"sec-edgar","filing":"0001213900-18-011213","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018011213/ownership.xml","form_type":"4"}},{"id":3976387,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Warrant to Purchase Common Stock","published_at":"2018-04-02T15:56:31.000Z","date":"2018-03-29","kind":"purchase","acquired":true,"shares":167504,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The warrant is fully vested and exercisable immediately."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The purchase price of the warrants was included in the purchase price of the common stock reported in Table I."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The warrant is fully vested and exercisable immediately."}],"balance_after":167504,"derivative":{"exercise_price":2.86,"expiration_date":"2023-09-29","underlying":"Common Stock","underlying_shares":167504},"source":{"system":"sec-edgar","filing":"0001213900-18-003856","document":"f4032918mazur_citiuspharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018003856/f4032918mazur_citiuspharma.xml","form_type":"4"}},{"id":3976386,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-04-02T15:56:31.000Z","date":"2018-03-29","kind":"purchase","acquired":true,"shares":167504,"price":2.985,"value":499999.44,"ownership":{"direct":true},"balance_after":3718340,"source":{"system":"sec-edgar","filing":"0001213900-18-003856","document":"f4032918mazur_citiuspharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018003856/f4032918mazur_citiuspharma.xml","form_type":"4"}},{"id":4104204,"issuer":{"id":7778,"kind":"organization","name":"Citius Pharmaceuticals, Inc."},"owners":[{"id":70982,"kind":"person","name":"Mazur Leonard L","position":1,"cik":"0001463414","reported_name":"Mazur Leonard L","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-08T16:05:39.000Z","date":"2017-12-19","kind":"purchase","acquired":true,"shares":213106,"price":4.69,"value":999467.14,"ownership":{"direct":true},"balance_after":3550836,"source":{"system":"sec-edgar","filing":"0001213900-18-000250","document":"f4121917mazur_citiuspharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1463414/000121390018000250/f4121917mazur_citiuspharma.xml","form_type":"4"}}]}